SAB Biotherapeutics, Inc. (SABS)
NCM · Common · CUSIP 78397T103
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for SABS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
78397T103 (prev. 089115109 )
Market Cap
Micro Cap
IPO
1/12/2021
Previous Symbol
BCYP (changed 10/22/2021)
Previous Name
Big Cypress Acquisition Corp.
Business: SAB Biotherapeutics is a clinical-stage biopharmaceutical company leveraging its novel DiversitAb™ platform to produce a new class of specifically targeted, high-potency, fully-human polyclonal antibodies without the need for human donors.

Company Contact

CEO
Samuel J. Reich
CFO
Lucy To
Headquarters
2100 East 54th Street North, Sioux Falls, SD 57104
Phone
605-679-6980
Investor Relations
Westwicke IR · SAbIR@westwicke.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »
Find all related securities for SABS »